Literature DB >> 18696021

The initial slope of the VCO2/VO2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction.

Joerg Honold1, Lenka Geiger, Birgit Assmus, Ulrich Fischer-Rasokat, Volker Schaechinger, Andreas M Zeiher, Ioakim Spyridopoulos.   

Abstract

BACKGROUND: Detecting heart failure (HF) patients at risk is a relevant clinical problem. Our goal was to define associations of clinical HF-markers and exercise parameters with respect to their prognostic power in HF-patients.
METHODS: We performed cardiopulmonary exercise testing (CPET) in 103 ischemic HF-patients. CPET-parameters included peak VO(2), VO(2) at AT, peak oxygen pulse, minimal CO(2) and O(2) equivalents, VE/VCO(2) and s1, a motivation-independent and submaximal parameter representing the initial slope of the VCO(2)/VO(2)-curve that has not been described in HF-patients so far.
RESULTS: Median follow-up was 668 days. The combined endpoint of cardiovascular death and rehospitalization due to HF occurred in 14 patients. Patients with/without events differed significantly regarding their age, NYHA-class, LVEF and NT-proBNP serum-levels. Patients with events had significantly lower peak VO(2)- and higher s1-values. NT-proBNP serum-levels, NYHA-class and LVEF were significantly correlated with peak VO(2). Only age, peak VO(2) and s1 were independent predictors of adverse events. Using multivariate analysis, s1 was a strong and independent parameter with good sensitivity and specificity.
CONCLUSION: s1 is an independent and powerful predictor in HF-patients. Since s1 is independent of maximal exercise capacity, s1 might be more accurate for the evaluation of HF-patients not willing or unable to perform maximal exercise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18696021     DOI: 10.1007/s00392-008-701-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  38 in total

1.  Extrapolated maximal oxygen consumption: a new method for the objective analysis of respiratory gas exchange during exercise.

Authors:  N P Buller; P A Poole-Wilson
Journal:  Br Heart J       Date:  1988-02

2.  Predictors of readmission among elderly survivors of admission with heart failure.

Authors:  H M Krumholz; Y T Chen; Y Wang; V Vaccarino; M J Radford; R I Horwitz
Journal:  Am Heart J       Date:  2000-01       Impact factor: 4.749

3.  24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization.

Authors:  G H Mudge; S Goldstein; L J Addonizio; A Caplan; D Mancini; T B Levine; M E Ritsch; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

4.  Dependence of peak oxygen uptake on oxygen transport capacity in chronic heart failure: comparison of graded protocol and fixed protocol.

Authors:  Y Yasaka; H Yamabe; M Yokoyama
Journal:  Int J Cardiol       Date:  1997-04-18       Impact factor: 4.164

5.  After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.

Authors:  Okcan Basat; Sema Ucak; Selcuk Seber; Erkan Oztekin; Yuksel Altuntas
Journal:  Clin Res Cardiol       Date:  2006-02-06       Impact factor: 5.460

6.  Factors affecting the components of the alveolar CO2 output-O2 uptake relationship during incremental exercise in man.

Authors:  C B Cooper; W L Beaver; D M Cooper; K Wasserman
Journal:  Exp Physiol       Date:  1992-01       Impact factor: 2.969

7.  Is the Ability index superior to the NYHA classification for assessing heart failure?: comparison of two classification scales in adolescents and adults with operated congenital heart defects.

Authors:  Kambiz Norozi; Armin Wessel; Reiner Buchhorn; Valentin Alpers; Jan O Arnhold; Monika Zoege; Siegfried Geyer
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

8.  Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers.

Authors:  Simon F Shakar; Brian D Lowes; Joann Lindenfeld; Ronald Zolty; Marc Simon; Alastair D Robertson; Michael R Bristow; Eugene E Wolfel
Journal:  J Card Fail       Date:  2004-02       Impact factor: 5.712

9.  Abnormalities of skeletal muscle in patients with chronic heart failure.

Authors:  D P Lipkin; D A Jones; J M Round; P A Poole-Wilson
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164

10.  Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy.

Authors:  F Peters-Klimm; T Müller-Tasch; D Schellberg; A Remppis; A Barth; N Holzapfel; J Jünger; W Herzog; J Szecsenyi
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

View more
  6 in total

Review 1.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Authors:  Mark Oremus; Andrew Don-Wauchope; Robert McKelvie; Pasqualina L Santaguida; Stephen Hill; Cynthia Balion; Ronald Booth; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

2.  Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension.

Authors:  Arthur Filusch; Thomas Zelniker; Christian Baumgärtner; Sabine Eschricht; Norbert Frey; Hugo A Katus; Emmanuel Chorianopoulos
Journal:  Clin Res Cardiol       Date:  2011-04-11       Impact factor: 5.460

3.  Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure.

Authors:  Joerg Honold; Ulrich Fischer-Rasokat; Florian H Seeger; David Leistner; Saskia Lotz; Stefanie Dimmeler; Andreas M Zeiher; Birgit Assmus
Journal:  Clin Res Cardiol       Date:  2013-04-24       Impact factor: 5.460

4.  Prevalence of ventricular discordance and its relation to functional capacity in idiopathic dilated cardiomyopathy.

Authors:  Gunnar Plehn; Julia Vormbrock; Lutz Lefringhausen; Marc van Bracht; Alexander Plehn; Thomas Butz; Hans-Joachim Trappe; Axel Meissner
Journal:  Clin Res Cardiol       Date:  2009-03-13       Impact factor: 5.460

5.  Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial.

Authors:  Vincent G Haver; Minke H T Hartman; Irene Mateo Leach; Erik Lipsic; Chris P Lexis; Dirk J van Veldhuisen; Wiek H van Gilst; Iwan C van der Horst; Pim van der Harst
Journal:  Clin Res Cardiol       Date:  2015-04-04       Impact factor: 5.460

6.  Power Output and Efficiency During Supine, Recumbent, and Upright Cycle Ergometry.

Authors:  Anja Wehrle; Sarah Waibel; Albert Gollhofer; Kai Roecker
Journal:  Front Sports Act Living       Date:  2021-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.